神经病学与神经康复学杂志2025，Vol.21Issue(6)：508-514,7.DOI:10.12022/jnnr.2025-0109
脑卒中后抑郁的早期药物治疗进展
Research progress on early antidepressant treatment of post-stroke depression patients
鞠艳敏 1刘训灿 1赵亮 1解希曦 1靳皓月 1邹小翠 1李贞兰1
作者信息
- 1. 吉林大学第一医院康复医学科,吉林 长春 130021
- 折叠
摘要
Abstract
Post-stroke depression(PSD)is one of the most common neuropsychiatric complications following stroke,with a high incidence rate.Depressive states inhibit the secretion of brain-derived neurotrophic factors and hinder neural repair.Early identification and intervention of PSD are crucial for patients'functional recovery,quality of life,and prognosis.Antidepressants can significantly improve depressive symptoms,and early use of antidepressants can also improve patients'motor and cognitive functions.Combining pharmacotherapy with exercise therapy and occupational therapy can enhance the effectiveness of drug treatment.Early intervention for PSD can correct patients'negative cognition towards post-stroke dysfunction,reduce the risk of depressive relapse,and avoid long-term psychosocial impairment.关键词
脑卒中后抑郁/抗抑郁药物/功能康复Key words
Post-stroke depression/Antidepressants/Functional rehabilitation引用本文复制引用
鞠艳敏,刘训灿,赵亮,解希曦,靳皓月,邹小翠,李贞兰..脑卒中后抑郁的早期药物治疗进展[J].神经病学与神经康复学杂志,2025,21(6):508-514,7.
